Get started
SPDR Series Trust SPDR S&P Biotech ETF
Short

13% down on XBI, 40% upside on LabD

117
Nice double top, retrace to the bottom of the channel, potential full breakdown depending on the broader market over the next month.
scarl
LABDTrend AnalysisXBI

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
LABDTrend AnalysisXBI
scarl

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.